Snapshots Czech Republic Pharmaceuticals 2009Mintel - SnapshotsApril 20, 2010 10 Pages - SKU: SNAP2649443 |
|
Biological Product (except Diagnostic) Manufacturing Industry in the U.S. and its International Trade [2013 Q2 Edition]
5/20/2013 | published by: Supplier Relations US, LLC
Dog and Cat Food Manufacturing Industry in the U.S. and its International Trade [2013 Q2 Edition] This 2013 publication of Dog and Cat Food Manufacturing Industry report is the comprehensive market research guide for the industry.
|
read more...
|
$599.00
|
|
Switzerland Pharmaceuticals and Healthcare Report Q2 2013
5/8/2013 | published by: Business Monitor International
BMI View: While the patent cliff and the consequent availability of generic drugs, as well as price cuts ongeneric medicines and their increasing affordability, will work towards increasing the consumption ofgeneric medicines in Switzerland, BMI
|
read more...
|
$1,175.00
|
|
Australia Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
BMI View: As a developed market, Australia represents opportunities for risk averse pharmaceuticalinvestors, given its ageing and generally affluent population. Importantly, the government is implementingcost-cutting measures to cope with escalating healthcare costs, therefore generic drugmakers
|
read more...
|
$1,175.00
|
|
Cameroon Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
BMI View: Despite the strong growth potential of its pharmaceutical market, we believe Cameroon isunlikely to be of significant interest to multinational pharmaceutical firms. The country's shortcomingsinclude poor public health provision and rampant corruption. Consequently
|
read more...
|
$1,175.00
|
|
Namibia Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
BMI View: We expect Namibia's negative pharmaceutical trade balance to widen as demand for medicinescontinues to be met by imports, and poor local manufacturing sees exports contract in the medium term.Headline Expenditure Forecasts Pharmaceuticals: NAD2.20bn
|
read more...
|
$1,175.00
|
|
Nigeria Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
Executive Summary BMI View: Boosting bilateral co-operation between Nigerian buyers and Indian drugmakers will directlyobstruct the Nigerian government's goal to increase self-sufficiency in medicines production. We do notbelieve implementing a selected import ban on pharmaceuticals should
|
read more...
|
$1,175.00
|
|
Russian Pharma Industry In Details
5/9/2013 | published by: Euroresearch & Consulting
Russian Pharma Industry In Details
Purpose of this report was to analyze Russian of pharma.
Please pay attention:
Benefits of buying the report:
The report included large volume
|
read more...
|
$3,750.00
|
|
Croatia Pharmaceuticals and Healthcare Report Q3 2013
5/15/2013 | published by: Business Monitor International
Executive Summary BMI View: Croatia's entrance into the EU will accelerate its economic liberalisation and the developmentof the country's private sector. It is also likely to bring about an influx of EU funding in modernising thecountry's
|
read more...
|
$1,295.00
|
|
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q3 2013
5/15/2013 | published by: Business Monitor International
BMI View: Sudan will remain one of the least attractive countries in the Middle East/Africa region due tolow pharmaceutical and healthcare expenditure. The government's low commitment to healthcare,combined with political and economic uncertainties, will remain
|
read more...
|
$1,295.00
|
|
Partnerships, Licensing, Investments and M&A Deals and Trends for April 2013 in Pharmaceuticals
5/15/2013 | published by: GlobalData
Partnerships, Licensing, Investments and M&A Deals and Trends for April 2013 in Pharmaceuticals Summary GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for April 2013 in Pharmaceuticals” report is an essential source of data and trend
|
read more...
|
$1,000.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Prescription Drugs Reports